Skip to content

To access the survey link to request your preferred COVID-19 treatment option, click here.

How Nebraska ASAP Is Making Everyone Antibiotic Aware

Written by Dr. M. Salman Ashraf, Nebraska ASAP Co-Medical Director Antibiotic Resistance is one of the most urgent threats to…

arrow_forward

The U.S. Antibiotic Awareness Week Kicks Off Today

          Today marks the start of the start of the U.S. Antibiotic Awareness Week.  Below is…

arrow_forward

U.S. Antibiotic Awareness Week is November 12-18, 2018

This year the U.S. Antibiotic Awareness Week (USAAW) will run between November 12 to 18.  Organized by the CDC, this…

arrow_forward

Does Piperacillin-Tazobactam Measure Up to Meropenem for ESBL Bloodstream Infections?

Extended-spectrum β-lactamase (ESBL)-producing Gram negative bacilli (GNB) have been classified by the CDC as a serious threat in its report…

arrow_forward

Implementing Antimicrobial Stewardship Efforts Across Different Healthcare Settings

 The CDC recommends implementation of antimicrobial stewardship efforts across various healthcare settings (acute, post-acute and long-term, and ambulatory care) as…

arrow_forward

Management of Common Infections in Long-Term Care

During the Nebraska Antimicrobial Stewardship Summit on June 1st, 2018, Dr. Christopher Crnich from the University of Wisconsin at Madison…

arrow_forward

New CDC Antibiotic Stewardship Training Targets Outpatient Settings

This week, CDC launched the second installment of the free web-based antibiotic stewardship training.  The first installment, which include 3…

arrow_forward

Antimicrobial Stewardship and Rapid Diagnostic Testing in Acute Care

Implementation of effective antimicrobial stewardship programs (ASP) typically requires a multipronged approach.  The Infectious Diseases Society of America (IDSA) and…

arrow_forward

What Happened at the Nebraska Antimicrobial Stewardship Summit?

After almost a year of planning, the First Annual Nebraska Antimicrobial Stewardship Summit convened on Friday, June 1st, 2018 in…

arrow_forward

Opportunities to Improve Fluoroquinolone Use in Adults Exist in Ambulatory Care Settings

Systemic fluoroquinolones* (FQ) currently in use include ciprofloxacin, levofloxacin, moxifloxacin, gemifloxacin, delafloxacin and ofloxacin.   These agents have a number of…

arrow_forward

IDSA and SHEA Update Clostridium difficile Infection Clinical Practice Guidelines

Clostridium difficile* infections (CDI) are associated with significant morbidity and mortality in the United States.  Based on data from 2006…

arrow_forward

FDA Issues New Safety Communication on Clarithromycin Use in Patients with Heart Disease

On February 22nd, the Food & Drug Administration (FDA) issued a new drug safety communication to health care providers regarding…

arrow_forward
Scroll To Top expand_less
Please provide your details below to reach out to our ASAP team on any questions about Antimicrobial Stewardship.

"*" indicates required fields

Address*
Name*